AU2002212187A1 - Diagnosis of illnesses or predisposition to certain illnesses - Google Patents
Diagnosis of illnesses or predisposition to certain illnessesInfo
- Publication number
- AU2002212187A1 AU2002212187A1 AU2002212187A AU1218702A AU2002212187A1 AU 2002212187 A1 AU2002212187 A1 AU 2002212187A1 AU 2002212187 A AU2002212187 A AU 2002212187A AU 1218702 A AU1218702 A AU 1218702A AU 2002212187 A1 AU2002212187 A1 AU 2002212187A1
- Authority
- AU
- Australia
- Prior art keywords
- illnesses
- predisposition
- diagnosis
- certain
- certain illnesses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10043826.1 | 2000-09-01 | ||
| DE10043826 | 2000-09-01 | ||
| PCT/EP2001/010073 WO2002018631A2 (en) | 2000-09-01 | 2001-09-01 | Diagnosis of illnesses or predisposition to certain illnesses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002212187A1 true AU2002212187A1 (en) | 2002-03-13 |
Family
ID=7655132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002212187A Abandoned AU2002212187A1 (en) | 2000-09-01 | 2001-09-01 | Diagnosis of illnesses or predisposition to certain illnesses |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20050064401A1 (en) |
| EP (1) | EP1373564A2 (en) |
| JP (1) | JP2005512499A (en) |
| AU (1) | AU2002212187A1 (en) |
| WO (1) | WO2002018631A2 (en) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6727230B1 (en) * | 1994-03-25 | 2004-04-27 | Coley Pharmaceutical Group, Inc. | Immune stimulation by phosphorothioate oligonucleotide analogs |
| US6207646B1 (en) * | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US20030026782A1 (en) * | 1995-02-07 | 2003-02-06 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
| EP0855184A1 (en) * | 1997-01-23 | 1998-07-29 | Grayson B. Dr. Lipford | Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination |
| US6406705B1 (en) * | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| US6693086B1 (en) * | 1998-06-25 | 2004-02-17 | National Jewish Medical And Research Center | Systemic immune activation method using nucleic acid-lipid complexes |
| US20030022854A1 (en) | 1998-06-25 | 2003-01-30 | Dow Steven W. | Vaccines using nucleic acid-lipid complexes |
| US7585847B2 (en) | 2000-02-03 | 2009-09-08 | Coley Pharmaceutical Group, Inc. | Immunostimulatory nucleic acids for the treatment of asthma and allergy |
| US20040131628A1 (en) * | 2000-03-08 | 2004-07-08 | Bratzler Robert L. | Nucleic acids for the treatment of disorders associated with microorganisms |
| KR100917101B1 (en) * | 2000-08-04 | 2009-09-15 | 도요 보세키 가부시키가이샤 | Flexible metal laminate and production method thereof |
| US7569553B2 (en) * | 2002-07-03 | 2009-08-04 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
| US7605138B2 (en) * | 2002-07-03 | 2009-10-20 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
| US20040053880A1 (en) * | 2002-07-03 | 2004-03-18 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
| US7576066B2 (en) * | 2002-07-03 | 2009-08-18 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
| US7807803B2 (en) * | 2002-07-03 | 2010-10-05 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
| AU2003257587A1 (en) * | 2002-08-23 | 2004-03-11 | Japan As Represented By President Of National Cancer Center | Method of evaluating degree of canceration of human-origin specimen |
| DK2241325T3 (en) * | 2002-10-29 | 2012-04-10 | Coley Pharm Group Inc | Use of CPG oligonucleotides to treat Hepatitis Cvirus infection |
| AU2003300919A1 (en) * | 2002-12-11 | 2004-06-30 | Coley Pharmaceutical Gmbh | 5' cpg nucleic acids and methods of use |
| US8158768B2 (en) | 2002-12-23 | 2012-04-17 | Dynavax Technologies Corporation | Immunostimulatory sequence oligonucleotides and methods of using the same |
| DK1575977T3 (en) * | 2002-12-23 | 2009-11-09 | Dynavax Tech Corp | Immunostimulatory sequence oligonucleotides and methods for using them |
| AU2004226605A1 (en) * | 2003-04-02 | 2004-10-14 | Coley Pharmaceutical Group, Ltd. | Immunostimulatory nucleic acid oil-in-water formulations for topical application |
| US20050013812A1 (en) * | 2003-07-14 | 2005-01-20 | Dow Steven W. | Vaccines using pattern recognition receptor-ligand:lipid complexes |
| KR100558851B1 (en) * | 2004-01-08 | 2006-03-10 | 학교법인연세대학교 | CJ oligodeoxynucleotide variants with increased immunomodulatory capacity |
| ES2587068T3 (en) * | 2006-04-17 | 2016-10-20 | Epigenomics Ag | Methods and nucleic acids for the detection of colorectal proliferative cell disorders |
| US8084734B2 (en) * | 2006-05-26 | 2011-12-27 | The George Washington University | Laser desorption ionization and peptide sequencing on laser induced silicon microcolumn arrays |
| AU2008334901A1 (en) * | 2007-12-11 | 2009-06-18 | Epigenomics Ag | Methods and nucleic acids for analyses of lung carcinoma |
| US20110117551A1 (en) * | 2008-02-19 | 2011-05-19 | Oncomethylome Sciences Sa | Detection and prognosis of lung cancer |
| CA2736233A1 (en) * | 2008-09-05 | 2010-03-11 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Predictive biomarkers |
| US8110796B2 (en) | 2009-01-17 | 2012-02-07 | The George Washington University | Nanophotonic production, modulation and switching of ions by silicon microcolumn arrays |
| US20120164238A1 (en) | 2009-02-03 | 2012-06-28 | Mdxhealth Sa | Methods of detecting colorectal cancer |
| US9490113B2 (en) * | 2009-04-07 | 2016-11-08 | The George Washington University | Tailored nanopost arrays (NAPA) for laser desorption ionization in mass spectrometry |
| WO2010149782A1 (en) * | 2009-06-26 | 2010-12-29 | Epigenomics Ag | Methods and nucleic acids for analysis of bladder cell proliferative disorders |
| US10752953B2 (en) | 2011-05-12 | 2020-08-25 | The Johns Hopkins University | Method of detecting cancer through generalized loss of stability of epigenetic domains, and compositions thereof |
| GB201121924D0 (en) * | 2011-12-20 | 2012-02-01 | Fahy Gurteen Labs Ltd | Detection of breast cancer |
| EP3230476B1 (en) | 2014-12-12 | 2020-02-05 | Exact Sciences Development Company, LLC | Zdhhc1 for normalizing methylation detection assays |
| US10465248B2 (en) * | 2014-12-12 | 2019-11-05 | Exact Sciences Development Company, Llc | Method of characterizing ZDHHC1 DNA |
| WO2016160454A1 (en) | 2015-03-27 | 2016-10-06 | Exact Sciences Corporation | Detecting esophageal disorders |
| DE102015009187B3 (en) * | 2015-07-16 | 2016-10-13 | Dimo Dietrich | Method for determining a mutation in genomic DNA, use of the method and kit for carrying out the method |
| DK3336197T3 (en) | 2016-12-16 | 2022-07-11 | Eurofins Genomics Europe Sequencing GmbH | EPIGENETIC MARKERS AND RELATED METHODS AND AGENTS FOR THE DETECTION AND TREATMENT OF OVARIAN CANCER |
| CN111635938B (en) * | 2020-04-30 | 2022-07-29 | 广州康立明生物科技股份有限公司 | Tumor detection reagent and kit |
| CN111676287B (en) * | 2020-06-03 | 2022-04-29 | 广州康立明生物科技股份有限公司 | Gene marker combination and application thereof |
| CN112195243A (en) * | 2020-09-22 | 2021-01-08 | 北京华大吉比爱生物技术有限公司 | Kit for detecting polygene methylation and application thereof |
| EP4453245A2 (en) * | 2021-12-23 | 2024-10-30 | Mammoth Biosciences, Inc. | Programmable nuclease-based assay improvements |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09507121A (en) * | 1993-10-26 | 1997-07-22 | アフィマックス テクノロジーズ ナームロゼ ベノートスハップ | Nucleic acid probe array on biological chip |
| DE19754482A1 (en) * | 1997-11-27 | 1999-07-01 | Epigenomics Gmbh | Process for making complex DNA methylation fingerprints |
-
2001
- 2001-09-01 JP JP2002522536A patent/JP2005512499A/en active Pending
- 2001-09-01 WO PCT/EP2001/010073 patent/WO2002018631A2/en not_active Ceased
- 2001-09-01 EP EP01980314A patent/EP1373564A2/en not_active Withdrawn
- 2001-09-01 US US10/363,483 patent/US20050064401A1/en not_active Abandoned
- 2001-09-01 AU AU2002212187A patent/AU2002212187A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005512499A (en) | 2005-05-12 |
| WO2002018631A3 (en) | 2003-10-16 |
| WO2002018631A2 (en) | 2002-03-07 |
| EP1373564A2 (en) | 2004-01-02 |
| US20050064401A1 (en) | 2005-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002212187A1 (en) | Diagnosis of illnesses or predisposition to certain illnesses | |
| AUPR005600A0 (en) | Diagnostic assay | |
| GB0101989D0 (en) | Improvements relating to information systems | |
| AU2002239370A1 (en) | Signal tampon | |
| AU2002359659A1 (en) | Cross reference to related application | |
| AU4671401A (en) | Bodily flow measuring system | |
| AUPR605601A0 (en) | Pipeite of sandwich construction | |
| AU2001252367A1 (en) | Improvements relating to computer systems | |
| AU2001290093A1 (en) | Clock | |
| AU2002234169A1 (en) | Measurement of electrophysiologic response | |
| AU2002359986A1 (en) | Period indicator | |
| EP1126339A3 (en) | Stopwatch | |
| AU2001232105A1 (en) | Improvements relating to data filtering | |
| AU2001258330A1 (en) | New uses of imidazolylmethyl-pyridines | |
| AU2002220913A1 (en) | Improvements relating to thermometers | |
| AU2001281123A1 (en) | Haplotypes of the isl1 gene | |
| AU2002222116A1 (en) | Improvements relating to information systems | |
| AU2001286890A1 (en) | Haplotypes of the scya2 gene | |
| AU2002216038A1 (en) | Preparation of monofluoroalkenes | |
| AU2001289288A1 (en) | Improvements relating to information systems | |
| AU2002342334A1 (en) | Obtaining information to facilitate system usage | |
| AU2002239511A1 (en) | Haplotypes of the gsr gene | |
| AU2002334465A1 (en) | Improvement to instrumentation | |
| GB9924457D0 (en) | Improvements to the transmission of information | |
| AU2001284319A1 (en) | Improvements relating to information exchange systems |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |